Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Sarissa Capital Management LP | 1.67M | $26.0M | 0.40% | -- | 2026-06-30 |
| Kynam Capital Management, LP | 533.0K | $8.0M | 0.13% | +60.6K | 2026-06-30 |
| Morgan Stanley | 223.6K | $3.0M | 0.05% | -69.6K | 2026-06-30 |
| Waterfront Wealth Inc. | 213.9K | $3.0M | 0.05% | +10.6K | 2026-06-30 |
| Brooklands Fund Management Ltd | 177.3K | $2.0M | 0.04% | +174.3K | 2026-06-30 |
| Eversept Partners, LP | 145.3K | $2.0M | 0.03% | -2.4K | 2026-06-30 |
| Citadel Advisors LLC | 124.5K | $1.0M | 0.03% | +32.9K | 2026-06-30 |
| Millennium Management LLC | 115.8K | $1.0M | 0.03% | -184.7K | 2026-06-30 |
| Two Sigma Investments, LP | 100.5K | $1.0M | 0.02% | -- | 2026-06-30 |
| BNP Paribas Financial Markets | 71.8K | $1.0M | 0.02% | -3.7K | 2026-06-30 |
